Evidence map›Paper›PMID 32761367›Full record

ArticleArchives of gynecology and obstetrics2021

Chromosomal microarray should be performed for cases of fetal short long bones detected prenatally.

Keren Tzadikevitch Geffen, Amihood Singer, Idit Maya, Lena Sagi-Dain, Morad Khayat, Shay Ben-Shachar, Hagit Daum, Rachel Michaelson-Cohen, Michal Feingold-Zadok, Rivka Sukenik Halevy

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Keren Tzadikevitch GeffenDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St, Kfar Saba, Israel. kerentzad@gmail.com.ORCID 0000-0002-4861-2941
Amihood SingerCommunity Genetics, Public Health Services, Ministry of Health, Jerusalem, Israel.
Idit MayaRabin Medical Center, Recanati Genetics Institute, Petah Tikva, Israel.
Lena Sagi-DainGenetics Institute, Carmel Medical Center, affiliated to the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Morad KhayatGenetics Institute, Emek Medical Center, Afula, Israel.
Shay Ben-ShacharSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hagit DaumDepartment of Genetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Rachel Michaelson-CohenGenetics Institute and Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Michal Feingold-ZadokSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rivka Sukenik HalevySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv University · ILEmek Medical Center · ILHadassah Medical Center · ILHebrew University of Jerusalem · ILIsrael Ministry of Health · ILRabin Medical Center · ILTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the prevalence of pathogenic and likely-pathogenic variants detected by chromosomal microarray analysis (CMA), among pregnancies with fetal short long bones diagnosed by ultrasound.

methodsThe study cohort was based on cases of chromosomal microarray analyses performed nationwide for the indication of short long bones.

resultsCMA was performed in 66 cases of short long bones. There were 4 cases with a pathogenic/likely pathogenic result (6%). The rate of chromosomal abnormalities was significantly higher compared to the background risk for copy number variations (CNVs) in pregnancies with no sonographic anomalies (P < 0.001). The yield of CMA in our cohort was significantly higher for both isolated and non-isolated cases, for cases in which the lowest estimated bone length percentile was above the 3rd percentile (below 5th percentile), and for cases diagnosed with short long bones after 22 weeks but not for cases diagnosed after 24 weeks.

conclusionThe yield of CMA in cases with short long bones (both isolated and non-isolated) is significantly higher than the background risk for chromosomal anomalies in pregnancies with no sonographic anomalies. This suggests that CMA should be offered in pregnancies with a diagnosis of fetal short long bones.

Indexed as

Chromosome AberrationsChromosome DisordersCohort StudiesDNA Copy Number VariationsFemaleFemurFetal Growth RetardationFetusHumansHumerusMicroarray AnalysisPregnancyPregnancy OutcomePrenatal DiagnosisPrevalenceUltrasonography, PrenatalChromosomal microarray analysisFetal short long bonesGrowth percentile

Identifiers

PMID32761367
OpenAlexW3047895722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.